Cargando…
Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors
Resistance mechanisms against antiangiogenic drugs are unclear. Here, we correlated the antitumor and antivascular properties of five different antiangiogenic receptor tyrosine kinase inhibitors (RTKIs) (motesanib, pazopanib, sorafenib, sunitinib, vatalanib) with their intratumoral distribution data...
Autores principales: | Torok, Szilvia, Rezeli, Melinda, Kelemen, Olga, Vegvari, Akos, Watanabe, Kenichi, Sugihara, Yutaka, Tisza, Anna, Marton, Timea, Kovacs, Ildiko, Tovari, Jozsef, Laszlo, Viktoria, Helbich, Thomas H., Hegedus, Balazs, Klikovits, Thomas, Hoda, Mir Alireza, Klepetko, Walter, Paku, Sandor, Marko-Varga, Gyorgy, Dome, Balazs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5197073/ https://www.ncbi.nlm.nih.gov/pubmed/28042343 http://dx.doi.org/10.7150/thno.16767 |
Ejemplares similares
-
Apelin promotes lymphangiogenesis and lymph node metastasis
por: Berta, Judit, et al.
Publicado: (2014) -
The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma
por: Laszlo, Viktoria, et al.
Publicado: (2018) -
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma
por: Hoda, Mir Alireza, et al.
Publicado: (2016) -
Apelin promotes blood and lymph vessel formation and the growth of melanoma lung metastasis
por: Berta, Judit, et al.
Publicado: (2021) -
Erythropoietin Receptor Expression Is a Potential Prognostic Factor in Human Lung Adenocarcinoma
por: Rózsás, Anita, et al.
Publicado: (2013)